Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: Comparison of limited versus comprehensive lymph node dissection in a 2-year safety study

Annals of Surgical Oncology

Volumn 15, Issue 7, 2008, Pages 2020-2026

  Son, Young Ik ^a   Jeong, Han Sin ^a   Baek, Chung Hwan ^a   Chung, Man Ki ^a   Ryu, Junsun ^b   Chung, Jae Hoon ^a   So, Yoon Kyung ^a   Jang, Jeon Yeob ^a   Choi, Jeesun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Lymph node dissection; Lymph node metastasis; Papillary carcinomas; Thyroid carcinomas

Indexed keywords

CALCIUM; IODINE 131; PARATHYROID HORMONE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; VITAMIN D;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CONTROLLED STUDY; DRUG MEGADOSE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPOCALCEMIA; INTERMETHOD COMPARISON; LOW DRUG DOSE; LUNG METASTASIS; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORBIDITY; NECK DISSECTION; PAPILLARY CARCINOMA; PARATHYROID HORMONE BLOOD LEVEL; PATIENT SAFETY; POSTOPERATIVE HEMORRHAGE; SURGICAL TECHNIQUE; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; VOCAL CORD PARALYSIS; WOUND INFECTION;

CARCINOMA, PAPILLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NECK; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 46149112753     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9928-8     Document Type: Article

References (23)

1. Ito Y, Tomoda C, Uruno T, et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 2006; 30:91-9.
2. Henry JF, Gramatica L, Denizot A, et al. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 1998; 383:167-9.
3. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16:109-42.
4. Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 2003; 237:399-407.
5. Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 2007; 245:604-10.
6. Pereira JA, Jimeno J, Miquel J, et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 2005; 138:1095-100, discussion 100-1.
7. Andersen PE, Cambronero E, Shaha AR, et al. The extent of neck disease after regional failure during observation of the N0 neck. Am J Surg 1996; 172:689-91.
8. Ferlito A, Rinaldo A, Robbins KT, et al. Neck dissection: past, present and future? J Laryngol Otol 2006; 120:87-92.
9. Sivanandan R, Kaplan MJ, Lee KJ, et al. Long-term results of 100 consecutive comprehensive neck dissections: implications for selective neck dissections. Arch Otolaryngol Head Neck Surg 2004; 130:1369-73.
10. Spiro RH, Morgan GJ, Strong EW, et al. Supraomohyoid neck dissection. Am J Surg 1996; 172:650-3.
11. Qubain SW, Nakano S, Baba M, et al. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 2002; 131:249-56.
12. Shindo M, Wu JC, Park EE, et al. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg 2006; 132:650-4.
13. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114:1050-7 discussion 7-8.
14. Voutilainen PE, Siironen P, Franssila KO, et al. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma. Anticancer Res 2003; 23:4283-8.
15. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981; 70:511-8.
16. Wada N, Suganuma N, Nakayama H, et al. Microscopic regional lymph node status in papillary thyroid carcinoma with and without lymphadenopathy and its relation to outcomes. Langenbecks Arch Surg 2007; 392:417-22.
17. McHenry CR, Rosen IB, Walfish PG. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 1991; 162:353-6.
18. Hughes CJ, Shaha AR, Shah JP, et al. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 1996; 18:127-32.
19. Sugino K, Kure Y, Iwasaki H, et al. Metastases to the regional lymph nodes, lymph node recurrence, and distant metastases in nonadvanced papillary thyroid carcinoma. Surg Today 1995; 25:324-8.
20. Lundgren CI, Hall P, Dickman PW, et al. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 2006; 106:524-31.
21. Grodski S, Cornford L, Sywak M, et al. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique. ANZ J Surg 2007; 77:203-8.
22. Sywak M, Cornford L, Roach P, et al. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 2006; 140:1000-5 discussion 5-7.
23. Cheah WK, Arici C, Ituarte PH, et al. Complications of neck dissection for thyroid cancer. World J Surg 2002; 26:1013-6.